{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:08:29Z","timestamp":1776118109049,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1016\/s0304-3940(02)00296-3","type":"journal-article","created":{"date-parts":[[2002,9,13]],"date-time":"2002-09-13T20:49:11Z","timestamp":1031950151000},"page":"155-158","source":"Crossref","is-referenced-by-count":191,"title":["Selective loss of 20S proteasome \u03b1-subunits in the substantia nigra pars compacta in Parkinson's disease"],"prefix":"10.1016","volume":"326","author":[{"given":"Kevin St.P","family":"McNaught","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Belizaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.Warren","family":"Olanow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Isacson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0304-3940(02)00296-3_BIB1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","article-title":"A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB2","first-page":"3000576","article-title":"Oxidative modification and inactivation of the proteasome during coronary occlusion\/reperfusion","volume":"276","author":"Bulteau","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB4","doi-asserted-by":"crossref","first-page":"15504","DOI":"10.1074\/jbc.271.26.15504","article-title":"Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome","volume":"271","author":"Grune","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB5","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1002\/ana.410440712","article-title":"Understanding cell death in Parkinson's disease","volume":"44","author":"Jenner","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0304-3940(02)00296-3_BIB7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0197-0186(00)00036-X","article-title":"Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation","volume":"37","author":"Lopiano","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/35086067","article-title":"Failure of the ubiquitin-proteasome system in Parkinson's disease","volume":"2","author":"McNaught","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures","volume":"81","author":"McNaught","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/bbrc.2000.3676","article-title":"Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats","volume":"277","author":"Noda","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB12","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0304-3940(02)00296-3_BIB13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","article-title":"Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases","volume":"29","author":"Sherman","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/S0304-3940(02)00296-3_BIB15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of {alpha}-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0304-3940(02)00296-3_BIB16","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0304-3940(02)00296-3_BIB17","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death","volume":"21","author":"Stefanis","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/10.9.919","article-title":"Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis","volume":"10","author":"Tanaka","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: a molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/S0304-3940(02)00296-3_BIB20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1083\/jcb.145.3.481","article-title":"Dynamic association of proteasomal machinery with the centrosome","volume":"145","author":"Wigley","year":"1999","journal-title":"J. Cell. Biol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394002002963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394002002963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T07:40:48Z","timestamp":1580888448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394002002963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0304394002002963"],"URL":"https:\/\/doi.org\/10.1016\/s0304-3940(02)00296-3","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}